Natco Pharma Ltd
Nagendra Babu is an experienced professional in the pharmaceutical industry, currently serving as an Executive at NATCO Pharma since January 2020, and previously held positions including Officer and Trainee at the same company. Prior to this role, Nagendra Babu worked as a Research Trainee at Pellets Pharma Ltd from April 2019 to December 2019. Educational qualifications include a Master of Pharmacy in Pharmaceutics from Chalapathi Institute of Pharmaceutical Sciences (2017-2019) and a Bachelor of Pharmacy from VALLABHANENI VENKATADRI INSTITUTE OF PHARMACEUTICAL SCIENCES (2013-2017), supplemented by an Intermediate in Biological and Physical Sciences from Sri Chaitanya Boys Junior College (2011-2013) and Secondary Education from Santhi Niketan School (1999-2011).
This person is not in any teams
This person is not in any offices
Natco Pharma Ltd
2 followers
Natco Pharma Limited is a pharmaceutical company. The Company is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The Company's segments include active pharmaceuticals ingredient, finished dosage formulations, job works, pharmacy and others. The Company's product categories include Domestic Formulations, International Formulations, API's and Blockbusters. The Company's products include Alphalan, Bandrone, Bendit, Clokeran, Lenalid, Thioplan, Anastronat, Capnat, Fulvenat, Kabanat, Natdox-LP, Rapact, Temonat, X-Trant, Glatimer, Hepcinat, Natdac, Natzold, Tigi, Alprazolam, Chloroquine Phosphate, Lansoprazole, Letrozole, Granisetron, Rizatriptan IR, Imatinib, Salmeterol Xinafoate, Sertraline Form I, Ibandronate Sodium Monohydrate, Pantoprazole Sodium Sesquihydrate, Ondansetron Hydrochloride (Injectable Grade), Daclatasvir and Glatiramer Acetate. The Company manufactures over 20 products under contract.